Speaker illustration

Professor Paul Hjemdahl

Karolinska University Hospital, Stockholm (Sweden)

Member of:

European Society of Cardiology

Senior professor/consultant, Clinical Pharmacology, Karolinska University Hospital/Solna. Research interests: sympatho-adrenal function and stress mechanisms in humans, hypertension, platelet function and antiplatelet therapy, chronic ischemic heart disease (APSIS study), diabetes, atrial fibrillation and oral anticoagulants. More than 300 original articles and >150 other publications. Tutored 28 PhD thesises. Previously much involved in ethics in research (Ethics Prize of the Karolinska Institute 2009). FESC 1996, FAHA 2001.

Concomitant oral anticoagulant and antidepressant therapy in patients with atrial fibrillation and risk of stroke and bleeding: a population based cohort study

Event: ESC Congress 2019

Topic: Oral Anticoagulation

Session: Atrial fibrillation and oral anticoagulation 1


High mortality in atrial fibrillation patients suffering ischemic stroke, intracranial hemorrhage or a gastrointestinal bleed and associations with the preceding antithrombotic treatment

Event: ESC Congress 2019

Topic: Stroke Prevention

Session: Prevention of thromboembolism and atrial remodelling in atrial fibrillation


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb